Xiaochun Wang

Xiaochun Wang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2022 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
LMLirong Mao
Lirong Mao
LXLifa Xu
Lifa Xu
XWXiaochun Wang
Xiaochun Wang
JDJianpeng Du
Jianpeng Du
QSQishan Sun
Qishan Sun
JZJingyan Zhang
Jingyan Zhang

5 November 2013 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
PDF file
KTKun Tan
Kun Tan
JLJinping Liang
Jinping Liang
XTXingtong Teng
Xingtong Teng
XWXiaochun Wang
Xiaochun Wang
JZJingyan Zhang
Jingyan Zhang
XFXionglin Fan
Xionglin Fan
Developing an effective adult prophylaxis vaccine is a high priority in the global control of tuberculosis (TB), because TB remains an important public health problem and the current widely used BCG vaccine provides effective protection only for children but variable protection against adult TB. BCG priming-heterologous vaccines booster and recombinant BCG technologies have been thought as two important regimens for inducing effective protection against adult TB. Obviously, defining the protective efficacy of the two regimens would benefit more rational design of the future adult TB vaccines. In this study, a recombinant BCG strain (rBCG::685A) expressing the fusion protein of ESAT-6 and Ag85A (r685A) of Mycobacterium tuberculosis was constructed successfully and the secretion of r685A protein from rBCG strain was confirmed by western blotting with anti-ESAT-6 and anti-Ag85A polyclonal antibodies, respectively. The immune responses and protective effects in rBCG::685A vaccinated C57BL/6 mice were compared with that of our previous reported BCG prime-pcD685A booster regimen. Boosting BCG with pcD685A DNA elicited higher level of r685A protein specific IFN-γ secreted by splenocytes and a more significant increase of both TNF-α and iNOS responses in the lung, thus providing better control of bacterial growth in both lung and spleen of immunized mice challenged with virulent M. tuberculosis, compared with mice vaccinated with rBCG::685A or BCG alone. Our results have implications for development of more effective adult TB vaccines for improved control of TB.

26 February 2022 in Tuberculosis
Verified
Journal Article
Closed access
LMLirong Mao
Lirong Mao
LXLifa Xu
Lifa Xu
XWXiaochun Wang
Xiaochun Wang
YXYingru Xing
Yingru Xing
JWJian Wang
Jian Wang
XWXinping Wang
Xinping Wang

23 January 2024 in Tuberculosis
Verified
Journal Article
Closed access
ZZZian Zhang
Zian Zhang
LXLifa Xu
Lifa Xu
XWXiaochun Wang
Xiaochun Wang
LKLingYun Kong
LingYun Kong
ZSZilun Shi
Zilun Shi
JWJianghong Wang
Jianghong Wang

27 March 2025 in Tuberculosis
Verified
Journal Article
Closed access
XWXiaochun Wang
Xiaochun Wang
YXYun Xu
Yun Xu
QZQiangsen Zhong
Qiangsen Zhong
ZZZian Zhang
Zian Zhang
LKLingYun Kong
LingYun Kong
SQSuwen Qiao
Suwen Qiao

5 October 2022 in Tuberculosis
Verified
Journal Article
Closed access
XWXiaochun Wang
Xiaochun Wang
JDJianpeng Du
Jianpeng Du
YZYanpeng Zhang
Yanpeng Zhang
TZTao Zhu
Tao Zhu
LMLirong Mao
Lirong Mao
LXLu Xia
Lu Xia